logo
#

Latest news with #Hill'sScienceDiet

Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET
Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

Business Wire

time21-07-2025

  • Business
  • Business Wire

Colgate-Palmolive Webcasts 2025 Second Quarter Earnings Conference Call August 1, 2025 – 8:30 a.m. ET

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 second quarter earnings conference call on Friday, August 1, 2025, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate's global business and how we are building a future to smile about, visit CL-E

Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share
Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share

Yahoo

time13-06-2025

  • Business
  • Yahoo

Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share

Colgate-Palmolive recently affirmed its commitment to delivering consistent value to shareholders by declaring a quarterly cash dividend of $0.52 per common share. The company's stock price experienced a notable 6% rise over the past month. This period also saw significant executive appointments, a positive indicator of strong leadership continuity. Despite broader market turbulence, including geopolitical tensions pushing the Dow Jones down 1.2%, CL's performance remained robust. These internal developments may have bolstered investor confidence, aligning with the broader market upswing that gained 1.6% over the last 7 days. We've spotted 1 risk for Colgate-Palmolive you should be aware of. We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent executive appointments and the declaration of a US$0.52 per share dividend by Colgate-Palmolive may suggest a continuity in strategic vision and commitment to shareholder returns. These developments could reinforce confidence among investors, as reflected in a 6% increase in the stock price over the past month, aligning with the company's resilient performance during a period of broader market volatility. In terms of historical performance, Colgate-Palmolive's shares have achieved a total return of 42.16% over the last five years, showing a strong long-term trajectory despite short-term fluctuations. Over the past year, the company exceeded the US Household Products industry performance, which saw a 2.7% decline, though it underperformed the broader US market's 11.7% return. The company's focus on innovation and premiumization, particularly with product relaunches like Colgate Total and Hill's Science Diet, could drive future revenue and earnings growth. Analysts forecast revenue to grow by 3.4% annually, with earnings expected to reach US$3.5 billion by 2028. Market challenges, particularly tariff impacts and softened conditions in China and Latin America, pose risks to these forecasts. Despite these challenges and the current share price of US$91.0, the analyst consensus price target stands at US$98.76, indicating optimism towards future growth. The modest gap between the current price and the target suggests analysts see Colgate-Palmolive as fairly priced on average, though this requires careful consideration of various growth and risk factors. Review our growth performance report to gain insights into Colgate-Palmolive's future. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share
Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share

Yahoo

time13-06-2025

  • Business
  • Yahoo

Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share

Colgate-Palmolive recently affirmed its commitment to delivering consistent value to shareholders by declaring a quarterly cash dividend of $0.52 per common share. The company's stock price experienced a notable 6% rise over the past month. This period also saw significant executive appointments, a positive indicator of strong leadership continuity. Despite broader market turbulence, including geopolitical tensions pushing the Dow Jones down 1.2%, CL's performance remained robust. These internal developments may have bolstered investor confidence, aligning with the broader market upswing that gained 1.6% over the last 7 days. We've spotted 1 risk for Colgate-Palmolive you should be aware of. We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent executive appointments and the declaration of a US$0.52 per share dividend by Colgate-Palmolive may suggest a continuity in strategic vision and commitment to shareholder returns. These developments could reinforce confidence among investors, as reflected in a 6% increase in the stock price over the past month, aligning with the company's resilient performance during a period of broader market volatility. In terms of historical performance, Colgate-Palmolive's shares have achieved a total return of 42.16% over the last five years, showing a strong long-term trajectory despite short-term fluctuations. Over the past year, the company exceeded the US Household Products industry performance, which saw a 2.7% decline, though it underperformed the broader US market's 11.7% return. The company's focus on innovation and premiumization, particularly with product relaunches like Colgate Total and Hill's Science Diet, could drive future revenue and earnings growth. Analysts forecast revenue to grow by 3.4% annually, with earnings expected to reach US$3.5 billion by 2028. Market challenges, particularly tariff impacts and softened conditions in China and Latin America, pose risks to these forecasts. Despite these challenges and the current share price of US$91.0, the analyst consensus price target stands at US$98.76, indicating optimism towards future growth. The modest gap between the current price and the target suggests analysts see Colgate-Palmolive as fairly priced on average, though this requires careful consideration of various growth and risk factors. Review our growth performance report to gain insights into Colgate-Palmolive's future. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

Colgate Declares Regular Quarterly Dividend
Colgate Declares Regular Quarterly Dividend

Yahoo

time12-06-2025

  • Business
  • Yahoo

Colgate Declares Regular Quarterly Dividend

NEW YORK, June 12, 2025--(BUSINESS WIRE)--The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on August 15, 2025, to shareholders of record on July 18, 2025. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate's global business and how we are building a future to smile about, visit CL-D View source version on Contacts Investor Relations: investor_relations@ Communications: colgate_palmolive_media_inquiry@

Momentum in Pet Business: A Catalyst for CL's Growth Phase?
Momentum in Pet Business: A Catalyst for CL's Growth Phase?

Yahoo

time11-06-2025

  • Business
  • Yahoo

Momentum in Pet Business: A Catalyst for CL's Growth Phase?

Colgate-Palmolive Company's CL pet care business remains a core strength and provides a competitive edge. As the pet industry gains traction, demand for high-quality products and services is rising. The advent of online purchasing has further bolstered the pet industry. Hence, CL has been making every possible effort to grab a larger share of the pet company is aggressively expanding its foothold in the pet industry by offering comprehensive pet care solutions. Colgate's pet business, commonly referred to as Hill's Pet Nutrition, remains committed to offering science-led pet nutrition solutions, focused on premium, veterinarian-led pet food. With the help of Hill's Pet Nutrition segment, the company has been a leader in specialty pet nutrition products for dogs and cats, with products marketed in more than 80 countries and territories worldwide. CL also plans to expand into the fresh pet food supplies pet foods under two labels, including Hill's Science Diet and Hill's Prescription Diet. Hill's Science Diet offers a range of products for everyday nutritional needs, whereas Hill's Prescription Diet spans a lineup of therapeutic pet foods to nutritionally aid dogs and cats in diverse stages of health. This February, Colgate has agreed to buy Care TopCo Pty Ltd, owner of the Prime100 pet food brand, to bolster its pet Hill's Pet Nutrition competes globally, selling through veterinarians as well as pet-supply and e-commerce retailers, and DTC channels. In first-quarter 2025, Hill's Pet Nutrition segment delivered sales of $1.1 billion, contributing about 23% to the overall quarterly sales. We expect the Pet Nutrition segment to register year-over-year growth of 1.3% in a nutshell, CL seeks to be a dominant player in the pet market by leveraging its Hill's Pet Nutrition division and expanding in the pet care aisle. This is likely to boost its overall revenues and aid growth. Tractor Supply Company TSCO, Chewy, Inc. CHWY and Central Garden & Pet Company CENT are the key companies competing with Colgate in the pet Supply is CL's key competitor in the pet care market. Tractor Supply has adopted a multi-channel approach, further buoyed by its Neighbor's Club loyalty program. Petsense, which is a fully-owned subsidiary of Tractor Supply and a pet specialty retailer, caters well to the needs of pet owners. TSCO has been striving to become a one-stop shop for pet owners. Pet owners can have easy access to TSCO's pet products, prescription medications and in-store services, including grooming and veterinary care. TSCO's pet business is likely to benefit from Petsense stores, the Allivet integration and the Tractor Supply Rx which operates as an e-commerce retailer for pet food and other related products, has been enhancing its presence in the pet market. CHWY has been making technology upgrades for its website and online platforms to aid online sales and be the perfect destination for pet lovers. Robust active customer growth and engagement, along with high Autoship customer loyalty, have been steadily contributing to its results. CHWY's healthcare business, which offers products and services spanning online pharmacy, telehealth, pet insurance and veterinary-led management tools, is encouraging. Central Garden & Pet has been a market leader in the pet and garden spaces, delivering innovative and trusted solutions. CENT's Pet segment consists of dog and cat supplies like treats and chews, toys, beds and containment, grooming products, waste management and training pads; supplies for aquatics, small animals, reptiles and pet birds such as toys, enclosures and habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live fish and small animals, and outdoor cushions. Central Garden & Pet has been advancing its growth strategy through innovation, e-commerce expansion and cost efficiencies across its Pet and Garden segments. Shares of Colgate have gained 2.6% year to date compared with the industry's growth of 0.7%. Image Source: Zacks Investment Research From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 24.40X compared with the industry's average of 20.77X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for CL's 2025 and 2026 EPS indicates year-over-year growth of 1.4% and 7.3%, respectively. The company's EPS estimate for 2025 has been stable, while the same for 2026 has gone north in the past 30 days. Image Source: Zacks Investment Research CL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tractor Supply Company (TSCO) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report Central Garden & Pet Company (CENT) : Free Stock Analysis Report Chewy (CHWY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store